封面
市场调查报告书
商品编码
1829312

2025年全球造影超音波市场报告

Contrast Enhanced Ultrasound Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,造影超音波市场规模稳定成长,从2024年的20.5亿美元增加到2025年的21.3亿美元,复合年增长率为4.1%。预测期内的成长可归因于诊断准确性和灵敏度的提高、非侵入性和安全性的提高、肝病盛行率的上升、全球人口老化以及对非放射技术的日益偏好。

预计未来几年,造影超音波市场规模将强劲成长,到2029年将达到26.7亿美元,复合年增长率为5.8%。预测期内的增长可归因于心血管疾病发病率的上升、儿科影像应用的不断增长、胃肠道影像作用的不断扩大、对精准医疗的日益关注以及与人工智慧的融合。预测期内的主要趋势包括持续创新、超音波技术的进步、肿瘤学应用的不断扩展、与多模态成像的融合、即时定量评估以及儿科应用。

造影造影超音波(CEUS) 是一种医学成像技术,利用造影剂或微气泡来提高超音波影像的可见度和清晰度。其应用范围包括器官内血液灌注成像以及测量心臟和其他身体器官的血流。

造影超音波的关键组成部分是设备和造影剂。设备包括用于执行特定任务、操作或功能的实体工具、机器、装置或仪器。此类设备包括使用造影剂产生即时影像的超音波诊断设备及相关设备。这些技术涵盖非标靶和标靶方法,可满足医院、诊所和各种其他应用的需求。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗器材产业产生了重大影响,尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要医疗器材重新认证,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company)造影报告系列的超音波,该系列提供造影超音波市场统计数据,例如全球市场规模、区域份额、竞争对手的市场份额、详细的造影超音波细分市场、市场趋势和造影造影超音波造影超音波提供您所需的一切信息,并详细分析了超音波行业的现状和未来趋势。

未来五年的预测成长率为5.8%,较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自瑞典和比利时等主要地区的微气泡造影剂和谐波成像换能器征收关税直接影响美国,从而导致成像品质下降和血管检查成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,这种影响也将更加广泛地显现。

慢性病盛行率的上升预计将显着推动造影超音波市场的成长。慢性病是需要持续管理和照护的长期疾病,而造影超音波(CEUS) 可提供诊断和监测这些疾病所需的详细即时影像。例如,世界卫生组织 (WHO) 在 2023 年 9 月报告称,每年约有 4,100 万人死于非传染性疾病 (NCD),占全球死亡总数的 74%。 CEUS 在这些情况下尤其有用,因为它可以可视化血流和组织灌注,有助于准确评估和管理慢性病。随着此类疾病的发生率持续上升,对造影超音波等先进诊断影像技术的需求预计将增加,从而进一步推动市场成长。

预计门诊手术中心数量的增加将推动造影超音波市场的成长。造影手术中心 (ASC) 专门提供门诊手术。这些中心采用超音波(CEUS) 技术,在微创手术过程中提供即时影像导引。根据 VMG Health 预测,到 2022 年,经认证的门诊手术中心总数将从 2021 年的 5,906 个增加到 6,028 个。因此,门诊手术中心数量的不断增加预计将推动造影超音波市场的成长。

造影超音波市场由提供诊断影像、治疗计画和监测等服务的营业单位所获得的收益所构成。市场规模还包括服务提供者销售或包含在其服务产品中的相关产品的价值。造影超音波市场还包括用于提供全面造影超音波的换能器、注射器、引导工具和影像软体的销售。该市场的价值是指“出厂价”,即产品製造商或创造者销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的产品价值。该市场中的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通膨、地缘政治、贸易战和关税,以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球造影超音波:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 最终用途产业分析
  • 全球造影超音波市场:增长率分析
  • 全球造影超音波市场表现:规模与成长,2019-2024
  • 全球造影超音波市场预测:规模与成长,2024-2029年,2034年
  • 全球造影超音波:总目标市场(TAM)

第六章 市场细分

  • 全球造影超音波市场(按产品、效能和预测),2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 造影
  • 全球造影超音波市场技术、效能及预测(2019-2024、2024-2029、2034)
  • 非目标
  • 目标
  • 全球造影超音波市场的应用、效能和预测,2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 其他的
  • 全球造影超音波市场:设备细分、类型、效能及预测(2019-2024 年、2024-2029 年、2034 年)
  • 超音波设备
  • 可携式超音波设备
  • 全球造影超音波市场:造影造影细分、类型、表现及预测,2019-2024 年、2024-2029 年、2034 年
  • 充气造影剂
  • 微气泡造影剂
  • 脂质造影剂

第七章 区域和国家分析

  • 全球造影超音波市场:按地区、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 全球造影超音波市场:国家、绩效及预测,2019-2024、2024-2029、2034

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章:德国市场

第18章:法国市场

第十九章:义大利市场

第20章:西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第30章:竞争格局与公司概况

  • 造影超音波市场:竞争格局
  • 造影超音波市场:公司简介
    • General Electric Company
    • Bayer AG
    • Bristol-Myers Squibb Company
    • Siemens Healthcare GmbH
    • Koninklijke Philips NV

第31章:其他领先和创新企业

  • Daiichi Sankyo Company Limited
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • JB Chemicals and Pharmaceuticals Ltd.
  • Canon Medical Systems
  • Lantheus Medical Imaging Inc.
  • Guerbet
  • Bracco Diagnostic Inc.
  • Esaote SpA
  • Trivitron Healthcare Pvt. Ltd.
  • BK Medical Holding Company Inc.
  • Hitachi Healthcare
  • Chison Medical Technology Co. Ltd.
  • SANOCHEMIA Pharmazeutika GmbH
  • SuperSonic Imagine SA
  • FUJIFILM Visualsonics Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章:市场潜力大的国家与策略

  • 2029 年造影超音波市场:提供新机会的国家
  • 2029 年造影超音波市场:细分市场带来新机会
  • 2029 年造影超音波市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r27782u

Contrast-enhanced ultrasound (CEUS) is a medical imaging technique that employs contrast agents or microbubbles to improve the visibility and clarity of ultrasound images. Its application extends to imaging blood perfusion in organs and measuring blood flow rates in the heart and other bodily organs.

The primary components of contrast-enhanced ultrasound are equipment and contrast agents. Equipment encompasses the physical tools, machinery, devices, or instruments designed to perform specific tasks, operations, or functions. This category includes ultrasound machines and associated devices utilized to generate real-time images using contrast agents. These technologies involve both non-targeted and targeted approaches, catering to the needs of hospitals, clinics, and various other applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The contrast enhanced ultrasound market research report is one of a series of new reports from The Business Research Company that provides contrast enhanced ultrasound market statistics, including the contrast enhanced ultrasound industry global market size, regional shares, competitors with contrast enhanced ultrasound market share, detailed contrast enhanced ultrasound market segments, market trends and opportunities, and any further data you may need to thrive in the contrast enhanced ultrasound industry. This contrast enhanced ultrasound market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The contrast enhanced ultrasound market size has grown steadily in recent years. It will grow from $2.05 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to diagnostic accuracy and sensitivity, non-invasiveness and safety, rising incidence of liver diseases, global increase in aging population, growing preference for non-radiation techniques.

The contrast enhanced ultrasound market size is expected to see strong growth in the next few years. It will grow to $2.67 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to rise in cardiovascular diseases, increasing applications in pediatric imaging, expanding role in gastrointestinal imaging, growing focus on precision medicine, integration with artificial intelligence. Major trends in the forecast period include continued technological innovations, advancements in ultrasound technology, expanding applications in oncology, integration with multimodal imaging, real-time quantitative assessment, pediatric applications.

The forecast of 5.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on microbubble contrast agents and harmonic imaging transducers, sourced from key regions such as Sweden and Belgium, which could lead to reduced diagnostic imaging quality and higher costs for vascular studies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is expected to significantly drive the growth of the contrast-enhanced ultrasound market. Chronic diseases are long-term medical conditions that require ongoing management and care, and contrast-enhanced ultrasound (CEUS) provides real-time, detailed imaging crucial for diagnosing and monitoring these conditions. For instance, in September 2023, the World Health Organization reported that approximately 41 million deaths annually, accounting for 74% of all global deaths, are attributed to non-communicable diseases (NCDs), which include many chronic diseases like liver cirrhosis and vascular disorders linked to hypertension. CEUS is particularly valuable in these contexts, as it enhances the visibility of blood flow and tissue perfusion, aiding in the accurate assessment and management of chronic diseases. As the incidence of these conditions continues to rise, the demand for advanced imaging techniques such as contrast-enhanced ultrasound is likely to increase, further propelling market growth.

The increasing number of ambulatory surgical centers is anticipated to contribute to the growth of the contrast-enhanced ultrasound market. Ambulatory Surgery Centers (ASCs) specialize in offering outpatient surgical procedures. Contrast-enhanced ultrasound (CEUS) finds application in these centers to provide real-time image guidance during minimally invasive procedures. In 2022, according to VMG Health, the total number of certified ambulatory surgical centers increased from 5,906 in 2021 to 6,028 centers in 2022. Therefore, the expanding presence of ambulatory surgical centers is expected to drive the contrast-enhanced ultrasound market's growth.

Major companies in the contrast-enhanced ultrasound market are focusing on developing advanced technologies, such as super-resolution contrast-enhanced ultrasound (CEUS) technology, to enhance spatial resolution. The integration of advanced technologies in contrast-enhanced ultrasound improves diagnostic capabilities, providing healthcare professionals with more detailed and accurate information about tissue and organ anatomy, function, and perfusion. In September 2023, Philips launched the Philips Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound (CEUS), utilizing advanced signal processing algorithms to enhance spatial resolution. This technology provides high-resolution images for diagnosing and treating various diseases, including cancer, liver disease, and vascular diseases.

In July 2024, GE HealthCare Technologies Inc., a US-based medical technology company, announced its acquisition of Intelligent Ultrasound Group PLC for an undisclosed amount. This strategic acquisition aims to integrate Intelligent Ultrasound's advanced solutions into GE HealthCare's existing ultrasound portfolio, enhancing both the efficiency and intelligence of their ultrasound offerings. The integration of these AI-driven technologies is expected to significantly improve the accuracy and usability of ultrasound systems, addressing the increasing demand for smarter imaging solutions within the healthcare industry. Intelligent Ultrasound Group PLC, based in the UK, specializes in innovative ultrasound systems, particularly focusing on applications related to contrast-enhanced ultrasound. This acquisition aligns with GE HealthCare's commitment to advancing imaging technologies and improving patient care through enhanced diagnostic capabilities.

Major companies operating in the contrast enhanced ultrasound market report are General Electric Company, Bayer AG, Bristol-Myers Squibb Company, Siemens Healthcare GmbH, Koninklijke Philips N.V., Daiichi Sankyo Company Limited, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., J.B. Chemicals and Pharmaceuticals Ltd., Canon Medical Systems, Lantheus Medical Imaging Inc., Guerbet, Bracco Diagnostic Inc., Esaote S.p.A., Trivitron Healthcare Pvt. Ltd., BK Medical Holding Company Inc., Hitachi Healthcare, Chison Medical Technology Co. Ltd., SANOCHEMIA Pharmazeutika GmbH, SuperSonic Imagine SA, FUJIFILM Visualsonics Inc., Leriva Pharma SA, Samsung Healthcare, Jodas Expoim Pvt Ltd., nanoPET Pharma GmbH, Alpinion Medical Systems, Acusphere Inc., ContextVision AB, Teratech Corporation, Solstice Pharmaceuticals B.V.

North America was the largest region in the contrast-enhanced ultrasound market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contrast enhanced ultrasound market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the contrast-enhanced ultrasound market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The contrast-enhanced ultrasound market consists of revenues earned by entities by providing services such as diagnostic imaging services, treatment planning services, and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The contrast-enhanced ultrasound market also includes sales of transducers, injectors, guidance tools, and imaging software that are used in providing comprehensive contrast-enhanced ultrasound. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contrast Enhanced Ultrasound Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contrast enhanced ultrasound market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for contrast enhanced ultrasound ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The contrast enhanced ultrasound market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Equipment; Contrast Agent
  • 2) By Technology: Non-targeted; Targeted
  • 3) By Application: Hospitals; Clinics; Other Applications
  • Subsegments:
  • 1) By Equipment: Ultrasound Machines; Portable Ultrasound Devices
  • 2) By Contrast Agent: Gas-filled Contrast Agents; Microbubble Contrast Agents; Lipid-based Contrast Agents
  • Companies Mentioned: General Electric Company; Bayer AG; Bristol-Myers Squibb Company; Siemens Healthcare GmbH; Koninklijke Philips N.V.; Daiichi Sankyo Company Limited; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; J.B. Chemicals and Pharmaceuticals Ltd.; Canon Medical Systems; Lantheus Medical Imaging Inc.; Guerbet; Bracco Diagnostic Inc.; Esaote S.p.A.; Trivitron Healthcare Pvt. Ltd.; BK Medical Holding Company Inc.; Hitachi Healthcare; Chison Medical Technology Co. Ltd.; SANOCHEMIA Pharmazeutika GmbH; SuperSonic Imagine SA; FUJIFILM Visualsonics Inc.; Leriva Pharma SA; Samsung Healthcare; Jodas Expoim Pvt Ltd.; nanoPET Pharma GmbH; Alpinion Medical Systems; Acusphere Inc.; ContextVision AB; Teratech Corporation; Solstice Pharmaceuticals B.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Contrast Enhanced Ultrasound Market Characteristics

3. Contrast Enhanced Ultrasound Market Trends And Strategies

4. Contrast Enhanced Ultrasound Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Contrast Enhanced Ultrasound Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Contrast Enhanced Ultrasound PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Contrast Enhanced Ultrasound Market Growth Rate Analysis
  • 5.4. Global Contrast Enhanced Ultrasound Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Contrast Enhanced Ultrasound Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Contrast Enhanced Ultrasound Total Addressable Market (TAM)

6. Contrast Enhanced Ultrasound Market Segmentation

  • 6.1. Global Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Equipment
  • Contrast Agent
  • 6.2. Global Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-targeted
  • Targeted
  • 6.3. Global Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Other Applications
  • 6.4. Global Contrast Enhanced Ultrasound Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound Machines
  • Portable Ultrasound Devices
  • 6.5. Global Contrast Enhanced Ultrasound Market, Sub-Segmentation Of Contrast Agent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gas-filled Contrast Agents
  • Microbubble Contrast Agents
  • Lipid-based Contrast Agents

7. Contrast Enhanced Ultrasound Market Regional And Country Analysis

  • 7.1. Global Contrast Enhanced Ultrasound Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Contrast Enhanced Ultrasound Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Contrast Enhanced Ultrasound Market

  • 8.1. Asia-Pacific Contrast Enhanced Ultrasound Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Contrast Enhanced Ultrasound Market

  • 9.1. China Contrast Enhanced Ultrasound Market Overview
  • 9.2. China Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Contrast Enhanced Ultrasound Market

  • 10.1. India Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Contrast Enhanced Ultrasound Market

  • 11.1. Japan Contrast Enhanced Ultrasound Market Overview
  • 11.2. Japan Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Contrast Enhanced Ultrasound Market

  • 12.1. Australia Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Contrast Enhanced Ultrasound Market

  • 13.1. Indonesia Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Contrast Enhanced Ultrasound Market

  • 14.1. South Korea Contrast Enhanced Ultrasound Market Overview
  • 14.2. South Korea Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Contrast Enhanced Ultrasound Market

  • 15.1. Western Europe Contrast Enhanced Ultrasound Market Overview
  • 15.2. Western Europe Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Contrast Enhanced Ultrasound Market

  • 16.1. UK Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Contrast Enhanced Ultrasound Market

  • 17.1. Germany Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Contrast Enhanced Ultrasound Market

  • 18.1. France Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Contrast Enhanced Ultrasound Market

  • 19.1. Italy Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Contrast Enhanced Ultrasound Market

  • 20.1. Spain Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Contrast Enhanced Ultrasound Market

  • 21.1. Eastern Europe Contrast Enhanced Ultrasound Market Overview
  • 21.2. Eastern Europe Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Contrast Enhanced Ultrasound Market

  • 22.1. Russia Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Contrast Enhanced Ultrasound Market

  • 23.1. North America Contrast Enhanced Ultrasound Market Overview
  • 23.2. North America Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Contrast Enhanced Ultrasound Market

  • 24.1. USA Contrast Enhanced Ultrasound Market Overview
  • 24.2. USA Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Contrast Enhanced Ultrasound Market

  • 25.1. Canada Contrast Enhanced Ultrasound Market Overview
  • 25.2. Canada Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Contrast Enhanced Ultrasound Market

  • 26.1. South America Contrast Enhanced Ultrasound Market Overview
  • 26.2. South America Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Contrast Enhanced Ultrasound Market

  • 27.1. Brazil Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Contrast Enhanced Ultrasound Market

  • 28.1. Middle East Contrast Enhanced Ultrasound Market Overview
  • 28.2. Middle East Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Contrast Enhanced Ultrasound Market

  • 29.1. Africa Contrast Enhanced Ultrasound Market Overview
  • 29.2. Africa Contrast Enhanced Ultrasound Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Contrast Enhanced Ultrasound Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Contrast Enhanced Ultrasound Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Contrast Enhanced Ultrasound Market Competitive Landscape And Company Profiles

  • 30.1. Contrast Enhanced Ultrasound Market Competitive Landscape
  • 30.2. Contrast Enhanced Ultrasound Market Company Profiles
    • 30.2.1. General Electric Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Contrast Enhanced Ultrasound Market Other Major And Innovative Companies

  • 31.1. Daiichi Sankyo Company Limited
  • 31.2. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.3. J.B. Chemicals and Pharmaceuticals Ltd.
  • 31.4. Canon Medical Systems
  • 31.5. Lantheus Medical Imaging Inc.
  • 31.6. Guerbet
  • 31.7. Bracco Diagnostic Inc.
  • 31.8. Esaote S.p.A.
  • 31.9. Trivitron Healthcare Pvt. Ltd.
  • 31.10. BK Medical Holding Company Inc.
  • 31.11. Hitachi Healthcare
  • 31.12. Chison Medical Technology Co. Ltd.
  • 31.13. SANOCHEMIA Pharmazeutika GmbH
  • 31.14. SuperSonic Imagine SA
  • 31.15. FUJIFILM Visualsonics Inc.

32. Global Contrast Enhanced Ultrasound Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contrast Enhanced Ultrasound Market

34. Recent Developments In The Contrast Enhanced Ultrasound Market

35. Contrast Enhanced Ultrasound Market High Potential Countries, Segments and Strategies

  • 35.1 Contrast Enhanced Ultrasound Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Contrast Enhanced Ultrasound Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Contrast Enhanced Ultrasound Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer